CAR-T cell therapy seeks strategies to harness cytokine storm.

Nature biotechnology

Volumn 32, Issue 7, 2014, Pages 604-

  DeFrancesco, Laura ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; LYMPHOCYTE ANTIGEN RECEPTOR;

ADOPTIVE IMMUNOTHERAPY; B CELL LYMPHOMA; BIOLOGICAL THERAPY; CLINICAL TRIAL (TOPIC); CYTOTOXICITY; HUMAN; IMMUNOLOGY; METHODOLOGY; NOTE; T LYMPHOCYTE; TRANSPLANTATION; TREATMENT OUTCOME;

CELL- AND TISSUE-BASED THERAPY; CLINICAL TRIALS AS TOPIC; CYTOKINES; CYTOTOXICITY, IMMUNOLOGIC; HUMANS; IMMUNOTHERAPY, ADOPTIVE; LYMPHOMA, B-CELL; RECEPTORS, ANTIGEN, T-CELL; T-LYMPHOCYTES; TREATMENT OUTCOME;

EID: 84908138667     PISSN: None     EISSN: 15461696     Source Type: Journal    
DOI: 10.1038/nbt0714-604     Document Type: Note

References (0)